May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Indocyanine Green–Mediated Photothrombosis (IMP) With Intravitreal Triamcinolone Acetonide for Macular Edema Secondary to Group 2A Idiopathic Parafoveal Telangiectasis Without Choroidal Neovascularization: A Pilot Study
Author Affiliations & Notes
  • J. Arevalo
    Retina and Vitreous, Clinica Oftalmologica Centro Caracas, Caracas, Venezuela
  • J.G. Sanchez
    Retina and Vitreous, Clinica Oftalmologica Centro Caracas, Caracas, Venezuela
  • R.A. Garcia
    Retina and Vitreous, Clinica Oftalmologica Centro Caracas, Caracas, Venezuela
  • L. Wu
    Retina and Vitreous, Instituto de Cirugia Ocular, San Jose, Costa Rica
  • M.H. Berrocal
    Retina and Vitreous, University of Puerto Rico, San Juan, Puerto Rico
  • F.J. Rodriguez
    Retina and Vitreous, Fundacion Oftalmologica Nacional, Bogota, Colombia
  • A. Rodriguez
    Retina and Vitreous, Fundacion Oftalmologica Nacional, Bogota, Colombia
  • Footnotes
    Commercial Relationships  J. Arevalo, None; J.G. Sanchez, None; R.A. Garcia, None; L. Wu, None; M.H. Berrocal, None; F.J. Rodriguez, None; A. Rodriguez, None.
  • Footnotes
    Support  The Arevalo–Coutinho Foundation for Research in Ophthalmology
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5193. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Arevalo, J.G. Sanchez, R.A. Garcia, L. Wu, M.H. Berrocal, F.J. Rodriguez, A. Rodriguez; Indocyanine Green–Mediated Photothrombosis (IMP) With Intravitreal Triamcinolone Acetonide for Macular Edema Secondary to Group 2A Idiopathic Parafoveal Telangiectasis Without Choroidal Neovascularization: A Pilot Study . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5193.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the feasibility, safety, and clinical effect of IMP combined with intravitreal triamcinolone acetonide (IVTA) in patients with macular edema secondary to idiopathic parafoveal telangiectasis (IPFT) group 2A without choroidal neovascularization (CNV).

Methods: : Nine eyes of 6 patients that were treated with IMP immediately followed by an intravitreal injection of 4 mg of TA participated in the study. Patients had a mean follow up of 22.6 months (range: 13 to 32 months). Patients underwent single to two sessions of IMP combined with IVTA. An IVTA without IMP group of 19 eyes from 14 patients with macular edema secondary to IPFT group 2A that had undergone an IVTA 4 mg without IMP was included for comparison. In addition, a control group of 34 eyes from 17 patients with macular edema secondary to IPFT group 2A without therapy was included.

Results: : Visual acuity (VA) showed stability in 5 eyes (55.5%), and improvement of VA (≥ 2 ETDRS lines) in 4 eyes (44.4%). A significant decrease of hyperfluorescence was not demonstrated with fluorescein angiography, however optical coherence tomography showed a decrease in the size of inner intraretinal hyporeflective spaces or cystic edema. We found no complications associated to the intravitreal injection procedure or IMP. Two (22.2%) eyes developed an increased in intraocular pressure related to the presence of TA in the vitreous cavity (controlled with topical medications). Cataract developed in 5 eyes (55.5%), and one of them required phacoemulsification and intraocular lens implantation. Six of 9 eyes (66.6%) required one retreatment during the study period. At the last follow up (mean: 17.3 months; range: 5–32 months) in the IVTA without IMP group, 5 (26.3%) improved VA (≥ 2 ETDRS lines), 11 (57.9%) remained within 2 lines of baseline VA, and 3 (15.8%) lost VA (≥ 2 ETDRS lines). In our control group with comparable follow up, all eyes showed deterioration of VA overtime.

Conclusions: : Combined IMP and IVTA may provide stability or improvement in visual acuity and fundus findings in macular edema secondary to IPFT group 2A without CNV. In addition, combined IMP and IVTA seem to be better than IVTA alone or natural history in these cases.

Keywords: macula/fovea • photodynamic therapy • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×